(Date:11/30/2009)... , COLUMBUS, Ohio, Nov. 30 T... for one of the nation,s first minority business e... in Cleveland December 3, is called "Transforming ...usiness Early-Stage Capital Summit." It will featu...minority business leaders and local minority entre...
(Date:11/30/2009)... , BLOOMINGTON, Minn., Nov. 30 /PRNewswire/ -...e medical image management software, data migratio...with Allina Hospitals and Clinics for a new Vendor...f image storage across the Allina network of hospi...solution is based on the Acuo Technologies DICOM S...
(Date:11/30/2009)... , BRIARCLIFF MANOR, N.Y., Nov. 30 /PRN...key guidance document for the publication of compa...online today by the British Medical Journal (BMJ)....tion of the importance of providing support and gu...lication of study results in the peer-reviewed med...
(Date:11/30/2009)... , CHANGCHUN, China and LOS ANGELES, N...n Pharmaceuticals, Inc. (OTC Bulletin Board: CYXN;..., a leading manufacturer, distributor and,retailer...nnounced it has,completed preparation for distribu..., The Chinese government recently formalized ...
Breaking Biology Technology:Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 2ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 3China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3(Date:12/1/2009)..., , MORRISVILLE, N.C., Dec. 1 /PRNewswi...der in the investigation of devices for minimally-...ounced the initiation of a feasibility clinical tr...f a combined surgical and catheter procedure, the ...atic paroxysmal atrial fibrillation (AF). This pr...
(Date:12/1/2009)..., , ALBUQUERQUE, N.M., Dec. 1 /PRNewswire/...ics laboratory that discovers, develops and market...ppointment of Scott Glenn as chairman of the compa...r. ,, Prior to joining Exagen, Glenn was managi...er of a number of successful biomedical companies ...
(Date:12/1/2009)..., , BRIDGEWATER, N.J., Dec. 1 /PRNewswir... Ortho Biotech Products, L.P., announced today tha...ess of issues affecting women and people of color ...aign including local educational events, media out... the company is sharing learnings from the GRACE s...
Breaking Medicine Technology:nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 2Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 3Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 4Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 5Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 6Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 7WaferGen to Present at the Rodman and Renshaw Annual Global Investment Conference 13843 1WaferGen to Present at the Rodman and Renshaw Annual Global Investment Conference 13843 2WaferGen to Present at the Rodman and Renshaw Annual Global Investment Conference 13843 3European Urology September issue features Surgery in Motion article 56200 1NCI renews Fox Chase Penn Ovarian Cancer SPORE grant for a third 5 year term 56198 1NCI renews Fox Chase Penn Ovarian Cancer SPORE grant for a third 5 year term 56198 2NCI renews Fox Chase Penn Ovarian Cancer SPORE grant for a third 5 year term 56198 3NCI renews Fox Chase Penn Ovarian Cancer SPORE grant for a third 5 year term 56198 4